Random Posts
- Different Ways To Treat Acne Scars
- Different Types of Allergies | ArticlesBase.com
- Rheumatoid Arthritis - Causes, Symptoms and Treatment | ArticlesBase.com
- An Effective Alternative Cure for Male Infertility | ArticlesBase.com
- Will Hemorrhoids Go Away on Their Own?
- Rest Of World H1N1 (swine flu) Vaccination Market | ArticlesBase.com
- Sciatica Stretching Exercises - Get Sciatica Relief Now
- How to Cure Acid Reflux - Effective Tips for the GERD Victim
- Diabetes Herbal Medicine - The Research is in on the Positive Benefits of Bitter Melon | ArticlesBase.com
- Fibromyalgia Symptoms - Discover What They Are and Which is the Most Important Symptom
Prescription Pain Killers
Drug Used For Neuropathic Pain Relieves Discomfort From Abdominal Adhesions: Henry Ford Study
Posted by admin in Prescription Pain Killers on July 20th, 2010
Pregabalin, FDA-approved for neuropathic pain (pain caused by shingles and peripheral neuropathy), effectively reduced abdominal pain and improved sleep in women with adhesions, according to a Henry Ford study.
Adhesion pain, a common complication after abdominal or pelvic surgery, currently lacks effective therapy. Adhesions can also form after infections in the bowel such as diverticulitis.
“Many patients in the study went from debilitating pain to complete resolution of pain on pregabalin,” says Ann Silverman, M.D., senior staff gastroenterologist at Henry Ford Hospital and lead author of the study.
Study results were presented at the American College of Gastroenterology’s Annual Scientific Meeting in San Diego.
“Aside from the use of analgesics, additional surgery is the only treatment option for abdominal pain from adhesions but repeat surgery can lead to more adhesions,” says Dr. Silverman.
The estimates of abdominal adhesion formation following surgery have been found to be as high as 100 percent in certain studies. Surgery is only recommended for bowel obstruction.
The randomized Henry Ford study looked at 18 women who received the drug or a look-alike placebo. All patients had previous abdominal surgery and were similar in age. The first eight weeks was a randomized placebo controlled trial of pregabalin followed by a four-week open label study in which all patients received the active study drug.
The primary objective was to demonstrate a significant reduction in pain scores.
The pain score result from the blinded phase indicated that the amount of decrease was significantly greater in the drug group (p-value = 0.024) compared with those on placebo, while the pain score resulted from the open label setting indicated that the amount of decrease was significantly greater in the placebo group (p-value = 0.043). This would be expected since those on active drug continued to take active drug and patients who had received the look-alike placebo received the active drug only during this phase of the study.
Funding: Pfizer
Source:
Maria Seyrig
Henry Ford Health System
- How To Protect Children From Corn Allergies
- Getting to the Bottom of Fibromyalgia
- Living With Chronic Pain & RSD - Surviving Real Life With Real Pain and Real Solutions
- Discover How to Stop Excessive Sweating
- Morning Heel Pain - 20 Tips For Treatment
- How to Cure Heartburn - Treating Your Heartburn Using 2 of the Best Herbal Remedies
- Should I Use Antibiotics Or Natural Treatments For Oral Yeast Infection Cure
- Could Acetaminophen Ease Psychological Pain?
- Reviews Of The Top Teeth Whitening Techniques to Whiten Your Teeth | ArticlesBase.com
- Ether Discovery Was Almost Made Earlier
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.